What is Biogen Inc?
discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 36.89B, and a P/E ratio of 108.0x.
A short list of Drug Manufacturers - General names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 21,186 shares $240k | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 23,408 shares $666k | 13 shares $585 |